Puma Biotechnology, Inc.PBYINASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+16.3%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+16.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$37.29M+20.4%
2024$30.97M-5.1%
2023$32.64M+37.6%
2022$23.72M+1738.8%
2021$1.29M+104.2%
2020$-30.40M+59.8%
2019$-75.59M+20.2%
2018$-94.70M+67.6%
2017$-292.40M-5.7%
2016$-276.60M-